Web of the Extended Myc Network Captures Metabolism for Tumorigenesis  by Dang, Chi V.
Cancer Cell
PreviewsWeb of the Extended Myc Network Captures
Metabolism for TumorigenesisChi V. Dang1,*
1Abramson Cancer Center, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA
*Correspondence: dangvchi@exchange.upenn.edu
http://dx.doi.org/10.1016/j.ccell.2015.01.004
In this issue of Cancer Cell, Carroll and colleagues describe the role of MondoA, a member of the Myc-Max-
Mxd-Mxl transcription factor network (termed the extended Myc network herein), in Myc-mediated alter-
ations in cancer cell metabolism and tumorigenesis.The extended Myc network (Figure 1A)
was revealed by the discoveryMax, which
heterodimerizes with Myc, binds DNA,
and contributes toMyc’s transforming ac-
tivity. Max lies at a nexus of the network
where it binds to other Myc family mem-
bers (N-Myc and L-Myc) as well as the
Mxd proteins, which were discovered
through the identification of Max-binding
proteins (Conacci-Sorrell et al., 2014). Us-
ing Mxd1 as a bait, Max-like (Mlx) was
identified as another nexus that extends
the Myc network and provides a hub for
oligomerization with the Mondo proteins
or Mxd’s to form a tapestry of transcrip-
tion factors involved in regulation of cell
growth and metabolism (Figure 1A).
Chief among the members of this
network is Myc, encoded by the MYC
gene, which is frequently amplified
in many human cancers. Deregulated
expression of Myc triggers tumorigenesis
across a wide spectrum of transgenic
mouse tissues, attesting to its causative
role in human cancers. MYCN, which en-
codes N-Myc, amplification and overex-
pression contribute to the development
of neuroblastoma, which profoundly af-
flicts children. The Myc-Max transcrip-
tional heterodimer drives mitogen-stimu-
lated or Myc-activated cells to grow
and proliferate by selective transcriptional
amplification of genes that are involved
in cellular acquisition of nutrients,
metabolism, mitochondrial function, and
biosynthesis of macromolecules required
for cell growth and cell cycle progression
(Wolf et al., 2014). Beyond Max, the role
of the extended Myc network in Myc-
regulated cell metabolism was not fully
understood, other than the discovery
of the role of MondoA in glucose and
glutamine metabolism (O’Shea and Ayer,
2013).160 Cancer Cell 27, February 9, 2015 ª2015In this issue of Cancer Cell, Carroll et al.
(2015) demonstrate a remarkable depen-
dency of Myc overexpressing cells on
MondoA expression for survival through
a synthetic lethal (SL) screen directed at
members of the extended Myc network.
The authors documented the SL effect
of siMondoA in many Myc-dependent
cell lines as well as N-Myc dependent
cell lines, one of which, Tet21N, was stud-
ied further. Induction of N-Myc in the
Tet21N cell line increased expression of
Max, Mlx, and MondoA, while endoge-
nous Myc and Mxd4 expression was
lowered. siMondoA treatment of Myc-
overexpressing cells caused cell death,
but only when Myc or N-Myc was
induced, corroborating the SL effect in
high Myc-expressing cells. Further, loss
of MondoA expression diminished in vivo
Tet21N tumor xenograft growth.
Because MondoA, which is related to
the carbohydrate response element bind-
ing protein ChREBP (Figure 1A), had been
shown to modulate metabolism by the
Ayer laboratory (O’Shea and Ayer, 2013),
the SL effect of MondoA loss-of-function
in Myc-overexpressing cells was pre-
sumed to be metabolic in nature. To gain
insight into the SL effect, transcriptional
changes induced by N-Myc activation
with or without MondoA expression were
measured in the Tet21N cells. Over 500
genes were significantly increased or
decreased by both N-Myc and MondoA,
while each transcription factor individ-
ually affected more than 2,000 and
1,500 genes, respectively. Through gene
ontology analysis, the overlap of N-Myc
and MondoA target genes was enriched
for genes involved in mitochondrial func-
tion, nucleotide metabolism, and amino
acid biosynthesis (Figure 1A). Genes
more restricted to MondoA were enrichedElsevier Inc.by those involved with sterol and choles-
terol metabolism or endoplasmic reticu-
lum, lysosome, peroxisome, and vacuolar
functions. It is particularly notable that
the majority of N-Myc induced genes
involved in cell cycle, ribonucleoprotein
complex, RNA processing, nucleolus,
and DNA metabolic processes did not
overlap with MondoA responsive genes
(Figure 1B). Collectively, these observa-
tions suggest that MondoA collaborates
with overexpressed N-Myc to boost
cellular metabolism in support of a highly
charged N-Myc-driven growth program,
which would collapse with an inadequate
supply of nutrients (Dang, 2012).
To delineate the critical metabolic
pathways, which are regulated by both
Myc and MondoA, selected metabolic
target genes were studied. Prominent
among these are the key glutamine
transporter Slc1a5, nucleotide synthetic
enzyme Pfas, mitochondrial complexes I
and IV, as well as the transcription factor
Srebp1, which were all induced by N-Myc
in a MondoA-dependent fashion. Further,
steady-state metabolomic analysis of
over 100metabolites revealed overlapping
and distinct effects of N-Myc andMondoA
on specific metabolic pathways. For
example,N-Mycmoreprofoundly affected
purinemetabolismand ammonia recycling
than MondoA, which affected amino acid
metabolism comparable to N-Myc and
uniquely affected specific lipid profiles.
Although Myc and MondoA profoundly
affect cell metabolism, which, if any, of
the pathways cause the SL effect in
Myc-overexpressing cells, is of para-
mount interest. Loss of MondoA expres-
sion in Myc-overexpressing cells was
associated with p53-independent cell
death, decreased glutamine metabolism,
lipogenesis, and diminished Bcl-2
Figure 1. Metabolic Basis for MondoA-Dependent Synthetic Lethal Effect in Myc-Overexpressing Cells
(A) The extended Myc network is illustrated at the top. This network of transcription factors, particularly Myc and MondoA, are shown to collaborate and drive
target genes. Sets of target genes with specific ontologies involved in growth andmetabolism are illustrated as horizontal bars (green, Myc specific; gray shading,
Myc and MondoA dependent; red, MondoA specific). When Myc is overexpressed, MondoA boosts the transcriptional program to balance the increased cell
growth demand of Myc with adequate nutrient supplies.
(B) The synthetic lethal loss of MondoA is depicted to result in a collapse of the Myc-induced transcriptional network, resulting in imbalanced metabolism,
oxidative stress, and cell death.
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Previewsexpression. Glutamine is required for
glutathione production and anaplerosis
and hence could play an important role
in the SL effect. In this regard, N-Myc
stimulated glutamine import was docu-
mented to be dependent on MondoA
expression. The expression of the gluta-
mine transporter, Slc1a5, depends not
only onMondoA but also on glucose, sug-
gesting an interplay between glucose
sensing and glutamine metabolism. In
this regard, Mondo proteins are thought
to sense glucose-6-phosphate and other
sugars directly, thereby connecting
glucose to glutamine metabolism (Stoltz-
man et al., 2011). Intriguingly, while gluta-
mine import is dependent on Myc and
MondoA, the SL effect could not be
rescued by a-ketoglutarate, which is
derived from glutamine, suggesting that
anaplerosismay not play a vital role. Since
siMondoA treatment was associated
with increased reactive oxygen species,
whether reduced glutamine contribution
to glutathione synthesis resulted in lethal
oxidative stress remain to be established
(Figure 1B).De novo lipogenesis in N-Myc over-
expressing cells depends on MondoA,
which is required for Myc-induced
expression of Srebp1. This was docu-
mented through isotopic labeling studies
using 13C-labeled glutamine that contrib-
uted carbons to the synthesis of long
chain fatty acids, such as palmitate,
which is monounsaturated to oleate. The
observation that oleate could partially
rescue the SL effect, which could not
be rescued by Bcl-2 overexpression, sug-
gests a role for lipogenesis in the death
phenotype. Not surprisingly, inhibitors of
fatty acid synthesis were toxic to high
Myc expressing cells. Collectively, these
results suggest that metabolic pathways
downstream of Myc and MondoA are
important for the survival of Myc-over-
expressing cells, particularly Srebp1-
dependent lipogenesis (Figure 1B).
Although Carroll et al. (2015) did not
further define why lipogenesis is critically
important for Myc-overexpressing cells,
several recent studies offer insights.
Overexpression of Myc results in the
unfolded protein response (UPR) inCancer Cell 27different cell systems as well as in
Drosophila (Hart et al., 2012; Nagy et al.,
2013). As a cell increase in mass, it re-
quires a balance between bioenergetic
consumption and demand as well as
proper protein folding and membrane
synthesis for homeostasis. With physio-
logical cell growth, endogenous Myc is
regulated within a complex network of
feed-forward and feed-back loops that
ensure a Myc-dependent transcrip-
tional program that results in balanced
stochiometries of biochemical reactions
and macromolecular syntheses for cell
growth. When Myc is overexpressed, the
non-linear transcriptional amplification of
its target genes presumably results in
imbalanced nutrient supply and demand,
which is re-balanced by MondoA that
boosts glutamine and lipid supplies for
cell growth (Figure 1A) (Wolf et al., 2014).
As such, loss of MondoA resulted in an
imbalance between supply and demand,
driving proteostatic and oxidative stress
that resulted in cell death (Figure 1B).
In this regard, it is notable that loss
of Srebp1 function resulted in UPR that, February 9, 2015 ª2015 Elsevier Inc. 161
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Previewscould be rescued partially by oleate
similar to the rescued SL effect with loss
of MondoA function (Griffiths et al.,
2013). As such, further studies to link the
extended Myc network with metabolism
are essential for our richer understanding
of the synthetic lethal metabolic vulnera-
bilities of Myc-overexpressing cancer
cells (Cermelli et al., 2014).REFERENCES
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